Assignee
SYNTONIX PHARMACEUTICALS INC
US·8 granted patents·2 pending applications·909 citations·filing 2004–2012
Top patents by PatentIndex Score
10 records- 0199US7381408B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 3, 2008·173 cites·26 claims
- 0298US7862820B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 4, 2011·120 cites·13 claims
- 0398US7404956B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·301 cites·48 claims
- 0498US7348004B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2005·Granted Mar 25, 2008·218 cites·20 claims
- 0597US7566565B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2007·Granted Jul 28, 2009·44 cites·22 claims
- 0696US7820162B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 26, 2010·26 cites·16 claims
- 0794US8021880B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2010·Granted Sep 20, 2011·17 cites·23 claims
- 0892US7795400B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2009·Granted Sep 14, 2010·10 cites·15 claims
- 0965US2013045218A1Fc receptor binding proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1049US2010048488A1Immunomodulatory peptidesSYNTONIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →